Real-world experience of angiotensin receptor neprilysin inhibitor on the glucose-lowering effect | Scientific Reports - Nature.com

Scientific Reports - Real-world experience of angiotensin receptor neprilysin inhibitor on the glucose-lowering effect

According to the 2017 ACC/AHA/HFSA, ARNIs (sacubitril/valsartan) have been recommended for patients with chronic HF to reduce morbidity and mortality in a stable state, rather than ACEIs or ARBs3. In… [+5848 chars]

full article...